Conferences

IAS 2013

NAM is the official provider of online scientific reporting at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), which will take place in Kuala Lumpur, Malaysia, 30th June-3rd July 2013.
The search for a cure

Two stem cell transplant recipients now controlling HIV off treatment

Harm reduction

Experts discuss role of drug policy in HIV, hepatitis and TB epidemics

Kidney problems

Loss of kidney function in older people with HIV underlines need for earlier treatment

Hepatitis C treatment

HIV/HCV co-infected people can do well on hepatitis C triple therapy despite contraindications

Side effects

Genetic testing lowers risk of nevirapine skin rash

Cancer

Vaccination could prevent infection with anal cancer-associated HPV strains in older gay men

Circumcision

Male circumcision: the message is catching on, but scale-up poses monitoring and follow-up problems

Diagnosing infants & children

Text messages to mothers improve early infant HIV diagnosis rates in Kenya and Mozambique

Retention & linkage to care

'Option B+' women are at increased risk of loss to follow-up after starting HIV treatment

Kidney problems

Kidney problems linked to tenofovir use, improve with switch to abacavir

Access to healthcare

Stigma, delay and misunderstanding slow access to ART in Africa

Human rights

Scientists and clinicians must challenge HIV-related stigma and ensure enabling legal and policy environments, IAS conference hears

HIV treatment for children & young people

Efavirenz in children: WHO dosing guidelines raise the risk of side-effects in Thai children

Access to healthcare

Non-African middle-income countries pay four times more for ARVs than African middle-income countries

HIV treatment for children & young people

Darunavir/ritonavir safe and effective for younger children

HIV treatment for children & young people

Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children

PrEP science

Magical thinking? FEM-PrEP trial may have failed because participants used testing as prevention

Harm reduction

Malaysia’s harm reduction programmes are preventing infections and saving money, but reaching far too few people who inject drugs

Hepatitis C symptoms & diagnosis

Fibroscan accurately predicts liver decompensation and death in HIV/HCV co-infected people

Bone & joint problems

Studies look at bone changes during second-line therapy, fractures, and HIV- and HCV-related bone loss

HIV prevention policy

Strategies to detect and treat MSM with acute infection may be a powerful tool to control HIV epidemics

New & experimental HIV treatments

Long-acting GSK1265744 and TMC278-LA appear safe and practical in early study

Undetectable viral load & treatment as prevention

No increase in risk behaviour in people taking antiretroviral therapy, meta-analysis shows

HIV treatment

First-line antiretroviral therapy has improved over time, meta-analysis shows

Economic & social inequality

Intervention with cash lottery prizes cuts HIV infection by 39% in young women in Lesotho

Undetectable viral load & treatment as prevention

Ambitious plans for treatment as prevention in Asia, but challenges remain

New & experimental HIV treatments

Dolutegravir superior to raltegravir for treatment-experienced people with HIV

Starting treatment

Reduced efavirenz dose suppresses HIV as well as standard dose

Changing treatment

Study supports WHO recommendations for second-line HIV therapy in resource-limited countries

PrEP science

Bangkok PrEP study finds PrEP efficacy is related to drug exposure

PrEP science

PrEP appears safe for use in conception, but may not be necessary if partner is taking treatment

Behaviour change interventions

First-ever community-randomised combination prevention trial produces modest drop in HIV incidence, big increase in testing in men

HIV testing programmes & uptake

How can most-at-risk populations be encouraged to seek HIV testing?

The search for a cure

Kick, kill, contain – researchers examine three possible steps in a cure for HIV

The search for a cure

Starting treatment at a CD4 count above 500 reduces the HIV reservoir for people with long-term infection

HIV testing programmes & uptake

Home visits during pregnancy increase number of male partners tested for HIV

The search for a cure

German researchers report case of 'functional cure' after very early HIV treatment

New & experimental hepatitis C treatment

AbbVie interferon-free hepatitis C combo works well with reduced ribavirin dose

Retention & linkage to care

High linkage to care after community-based HIV counselling and testing in South Africa associated with confidence in drug supplies, depression

Hepatitis C transmission & prevention

Hepatitis C reinfection occurs frequently among gay men living with HIV in London

HIV treatment for children & young people

New recommendations on HIV treatment for children require earlier diagnosis, new drug combinations for maximum impact

Men who have sex with men (MSM)

Turning surveillance into support for men who have sex with men in Africa

HIV testing programmes & uptake

High positivity rate and good linkage to care at Barcelona community testing project

Ageing & HIV

Management of age-related conditions is 'the future of HIV care', says IAS conference keynote speaker

The search for a cure

Cure research is new phase of HIV therapy, says US AIDS chief

Treatment guidelines

WHO issues new HIV recommendations calling for earlier ARV initiation